Literature DB >> 5127796

Kinetics of mammary tumor cell growth and implications for therapy.

H E Skipper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5127796     DOI: 10.1002/1097-0142(197112)28:6<1479::aid-cncr2820280622>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  40 in total

1.  Recombinant filgrastim (BK0023) pharmacodynamics and pharmacokinetics after single and multiple escalating doses in an equivalence study in healthy men.

Authors:  Andrea F D Di Stefano; Gaia Spinetti; Antonio Rusca; Milko M Radicioni; Luca Loprete; Domenica M G Lamparelli; Jutta Michael Hepp; Davide Crobu; Rodolfo Schrepfer; Giancarlo Tonon
Journal:  Clin Drug Investig       Date:  2015-09       Impact factor: 2.859

Review 2.  [Problems and principles of hormone therapy of advanced prostate cancer].

Authors:  J E Altwein; P Faul
Journal:  Klin Wochenschr       Date:  1990-04-02

3.  Advances in the treatment of carcinoma of the breast.

Authors:  L H Smith; M Bozdech
Journal:  West J Med       Date:  1976-11

4.  Stability analysis of normal and neoplastic growth.

Authors:  M Eisen; J Schiller
Journal:  Bull Math Biol       Date:  1977       Impact factor: 1.758

5.  Weight-based chemotherapy dosing in obese patients with cancer: back to the future.

Authors:  Gary H Lyman
Journal:  J Oncol Pract       Date:  2012-04-03       Impact factor: 3.840

6.  Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy.

Authors:  Triona Ni Chonghaile; Kristopher A Sarosiek; Thanh-Trang Vo; Jeremy A Ryan; Anupama Tammareddi; Victoria Del Gaizo Moore; Jing Deng; Kenneth C Anderson; Paul Richardson; Yu-Tzu Tai; Constantine S Mitsiades; Ursula A Matulonis; Ronny Drapkin; Richard Stone; Daniel J Deangelo; David J McConkey; Stephen E Sallan; Lewis Silverman; Michelle S Hirsch; Daniel Ruben Carrasco; Anthony Letai
Journal:  Science       Date:  2011-10-27       Impact factor: 47.728

7.  Cyclical sequential hormonochemotherapy in advanced breast cancer.

Authors:  M W Ghilchik; N A Shaikh; P A Beranek; M J Reed
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-07

Review 8.  The impact of non-genetic heterogeneity on cancer cell death.

Authors:  Zintis Inde; Scott J Dixon
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-12-18       Impact factor: 8.250

Review 9.  Preoperative chemotherapy in operable breast cancer. The influence of timing FEC in relation to surgery.

Authors:  C J van de Velde
Journal:  Drugs       Date:  1993       Impact factor: 9.546

10.  Relative dose intensity delivered to patients with early breast cancer: Canadian experience.

Authors:  S Raza; S Welch; J Younus
Journal:  Curr Oncol       Date:  2009-12       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.